With regard to Human and Animal Health, the majority of responding customers
and competitors considered that innovation in the market by all players will either not be significantly affected, or will be positively affected.331 Only one out of 17 responding customers, and a minority of responding competitors, considered that innovation will be negatively affected. In the same vein, the majority of responding end-customers considered that innovation by the merged entity will either not change significantly or will improve. Only one out of 18 responding customers considered that innovation by the merged entity would decrease. One customer explained: “I don't see a potential market control after this merge[r] as there are options and generics coming continuously to the animal production market.”332 Another customer explained: “[Customer] has the impression that with this merger both partners combined will become a more strategic partner for [Customer] in the future.”333 Another customer explained that: “[s]ynergies in the merged entity wo[u]ld probably impact positively innovation and, therefore, this would also improve innovation in the overall market (all players).”334